Logos Global Management LP

13D and 13G Filings

Issuer % of Class Filed
Schedule 13D · 3 securities · may seek to influence control
Design Therapeutics, Inc. 13D/A
DSGN · 25056L103
4.4% 11/18/2025
Event 11/14/2025
Arvinas, Inc. 13D/A
ARVN · 04335A105
3.4% 10/15/2025
Event 10/13/2025
Olema Pharmaceuticals, Inc. 13D/A
OLMA · 68062P106
4.7% 5/13/2025
Event 3/18/2025
Schedule 13G · 17 securities · passive
Yarrow Bioscience, Inc. 13G/A
YARW · 92941V407
10.0% 11/17/2026
Event 9/30/2026
Xilio Therapeutics, Inc. 13G
XLO · 98422T209
10.0% 11/16/2026
Event 6/5/2025
Yarrow Bioscience, Inc. 13G/A
YARW · 92941V407
10.0% 11/16/2026
Event 9/30/2026
Achieve Life Sciences, Inc. 13G/A
ACHV · 004468500
8.6% 11/16/2026
Event 9/30/2026
Longeveron Inc. 13G
LGVN · 54303L302
6.3% 9/10/2026
Event 9/2/2026
Tenax Therapeutics, Inc. 13G/A
TENX · 88032L605
3.0% 5/15/2026
Event 3/31/2026
Palatin Technologies Inc 13G/A
PTN · 696077601
9.9% 5/15/2026
Event 3/31/2026
iBio, Inc. 13G/A
IBIO · 451033708
0% 5/15/2026
Event 3/31/2026
Avalo Therapeutics, Inc. 13G/A
AVTX · 05338F306
3.2% 5/15/2026
Event 3/31/2026
Minerva Neurosciences, Inc. 13G
NERV · 603380205
9.9% 2/17/2026
Event 12/23/2025
Verastem, Inc. 13G/A
VSTM · 92337C203
4.8% 11/14/2025
Event 9/30/2025
Erasca, Inc. 13G/A
ERAS · 29479A108
4.8% 11/14/2025
Event 9/30/2025
Crescent Biopharma, Inc. 13G/A
CBIO · G2545C104
4.1% 8/14/2025
Event 6/30/2025
Prothena Corp Public Ltd Co 13G/A
PRTA · G72800108
0% 8/14/2025
Event 6/30/2025
Annexon, Inc. 13G/A
ANNX · 03589W102
0% 8/14/2025
Event 6/30/2025
NextCure, Inc. 13G/A
NXTC · 65343E108
0% 2/14/2025
Event 12/31/2024
Elevation Oncology, Inc. 13G/A
ELEV · 28623U101
0% 2/14/2025
Event 12/31/2024

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.